DGCRF Stock UPDATES Diagnocure Inc (DGCRF) 0.1290 09/23/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Diagnocure Inc (DGCRF) 0.1290 $DGCRF

DiagnoCure announces results for third quarter of 2014
PR Newswire - Thu Sep 11, 4:01PM CDT
DiagnoCure, Inc. (TSX: CUR) (OTCQX: DGCRF) (the "Corporation" today reported financial and operational results for the third quarter 2014 ended July 31, 2014. The Corporation announced a net loss of $504,105 or $0.01 per share for this quarter compared with a loss of $595,262 or $0.01 per share for the same period last year. During the third quarter ended July 31, 2014, total revenues decreased by 19% compared with the same quarter of 2013, due to a decrease in PCA3 royalties paid to DiagnoCure. Operating expenses decreased by $127,318 or 16%, to $657,529 for the third quarter of 2014 from $784,847 for the same period of 2013. At the end of the quarter, cash and short-term investments stood at $2,541,852.

DiagnoCure Announces First Quarter 2014 Results
PR Newswire - Fri Mar 14, 4:22PM CDT
DiagnoCure, Inc. (TSX: CUR) (OTCQX: DGCRF) (the "Corporation" today reported financial and operational results for the first quarter 2014 ended January 31, 2014. The Corporation announced a net loss of $529,739 or $0.01 per share for this quarter. At the end of the quarter, cash, cash equivalents and short-term investments stood at $3,543,029.

DiagnoCure announces fourth quarter 2013 and year-end results
CNW Group - Thu Jan 16, 3:00PM CST
Providing Corporate Update on Key Projects

Allstate Looking to Add at Least 550 Sales Jobs in Seven States in 2014
Michael Buck - AMBest - Tue Jan 14, 2:04PM CST
Allstate Corp. is expanding its sales force in three Midwest and four Southwest states, looking to add at least 550 new positions this year, according to written statements from the company.

DiagnoCure to host Q4 2013 and full year earnings conference call and webcast
PR Newswire - Mon Jan 13, 3:00PM CST
DiagnoCure Inc. (TSX: CUR; OTCQX: DGCRF) announced today that the Corporation will release its fourth quarter and fiscal year 2013 operating results on January 16, 2014, at 4:00p.m. (ET). DiagnoCure's management will host a conference call the same day, at 4:30 p.m. (ET). Interested participants may listen to the call by dialing 1-888-390-0546 or 514-225-6995 and referencing code 50137031 approximately 15 minutes prior to the call. The Corporation will also provide a live webcast of the call. Interested participants may access the webcast on DiagnoCure's website at www.diagnocure.com, through a link on the Investors page- Presentations. A replay of the webcast will be available on DiagnoCure's website for those unable to participate in the live webcast.

2013 Report on the International Molecular Diagnostics Markets
M2 - Mon Jan 13, 6:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/82rrrq/molecular) has announced the addition of the "Molecular Diagnostics Markets" report to their offering. This report helps readers by Identifying viable technology drivers through a comprehensive look at platform technologies for molecular diagnostics, including probe-based nucleic acid assays, microarrays and sequencing. Readers will also obtain a complete understanding of the chief molecular diagnostics tests--i.e., predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic--from their basic principles to their applications; The research will help people discovering feasible market opportunities by identifying high-growth applications in different clinical diagnostic areas and by focusing on expanding markets, such as communicable diseases, cardiology and oncology; By focusing on global industry development through an in-depth analysis of the major world markets for molecular diagnostics, including growth forecasts, readers will gain a thorough understanding of the molecular diagnostic market. Key Topics Covered: 1. Overview 2. Introduction to Molecular Diagnostics and PCR Technology 3. Business Landscape for the Molecular Diagnostics Market Sectors 4. Overview of Clinical Molecular Diagnostic Platforms on the Market 5. Molecular Diagnostic Testing and Infectious Diseases 6. Cancer Detection Using Molecular Diagnostics 7. Genetics Testing in Molecular Diagnostics 8. Molecular Diagnostics Uses in Industrial Testing and Food Diagnostics 9. Bioterrorism and Molecular Diagnostics 10. Regulatory Requirements 11. Reimbursement Issues and Billing Landscape for Molecular Diagnostics Testing 12. Company Profiles Companies Mentioned: - Abbott Laboratories - Beckman Coulter - Cancer Genetics, Inc - DiagnoCure, Inc - Exiqon - Genera Biosystems - Hologic - Illumina - Luminex - Myriad Genetics, Inc - Nanosphere - Orion Genomics - PerkinElmer Genetics - Progenika - QIAGEN NV - Roche Diagnostics - Rosetta Genomics Ltd - Seegene - Sequenom, Inc - Siemens Healthcare Diagnostics (Siemens) - Spartan Bioscience - Thorne Diagnostics - Transgenomic - TrimGen - Trovagene, Inc - Veredus Laboratories - Veridex For more information visit http://www.researchandmarkets.com/research/82rrrq/molecular

Stroock Names Three New Partners
PR Newswire - Tue Jan 07, 9:30AM CST
Stroock & Stroock & Lavan LLP, a national law firm with offices in New York, Los Angeles, Miami and Washington, DC, named three new partners, effective January 1, 2014.

Diagnocure Grants Stock Options To Senior Advisor
CNW Group - Tue Sep 17, 6:30AM CDT
Vesting Linked To Improvement of Shareholder Value

DiagnoCure announces third quarter 2013 results
CNW Group - Wed Sep 04, 3:00PM CDT
Strong Royalty Revenues Increase of 39 % from Hologic Gen-Probe partnership

DiagnoCure to host Q3 2013 earnings conference call and webcast
PR Newswire - Tue Aug 27, 6:30AM CDT
DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) announced today that it will release its third quarter 2013 results on September 4, 2013, at 4:00 p.m. (EDT). DiagnoCure's management will host a conference call the same day, at 4:30 p.m. (EDT). Interested participants may listen to the call by dialing 1-888-390-0546 or 514-225-6995 and referencing code 78274536 approximately 15 minutes prior to the call. The Corporation will also provide a live webcast of the call. Interested participants may access the webcast on DiagnoCure's website at www.diagnocure.com, through a link on the Investors page- Presentations. A replay of the webcast will be available on DiagnoCure's website for those unable to participate in the live webcast.

DiagnoCure appoints Richard Bordeleau as Senior Advisor to the board
CNW Group - Tue Aug 20, 6:30AM CDT
Appointment Targeting Next Steps to Increasing Shareholder Value

Cancer Diagnostics: A Global Analysis - Report Includes Dollar Volume of Sales For Tumor Marker Testing Equipment by Market and Discusses Competitors In-Depth
M2 - Thu Jul 18, 12:12PM CDT
Research and Markets (http://www.researchandmarkets.com/research/pp2l5q/cancer_diagnostic) has announced the addition of the "Cancer Diagnostics: A Global Analysis" report to their offering. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs of the disease are $126 billion annually. Pharmaceutical companies are developing more than 300 new medicines for cancer, some of which are in development for more than one type of the disease, for a total of more than 500 ongoing R&D projects. The goal of this report is to review the market for tumor marker testing equipment and supplies using screening reagents and instruments for analysis of individual components in blood, serum or plasma. It defines the dollar volume of sales, both worldwide and in the U.S., and analyzes the factors that influence the size and the growth of the market segments. Also examined are the subsections of each market segment, including: the physician office labs, hospital labs and commercial laboratories. Additionally, the numbers of institutions using this type of testing and the factors that influence purchases are discussed. The report surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the clinical point-of-care market in the U.S. Each company is discussed in depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Key Topics Covered: 1. Overview 2. Introduction to Cancer Biology and the Diagnostic Industry 3. Tumor Markers Market Segment Analysis: Size, Growth and Share 4. Diagnostic Methods for Cancer Detection 5. Implications of Molecular Biology for New Diagnostic Cancer Tests 6. Companies Entering the Cancer Diagnostics Market with Novel Technology Platforms 7. Business Trends in the Industry 8. Tumor Marker Testing: Important Issues 9. Important New Technology Areas 10. New Cancer Markers in Basic Research 11. Market Trends and Forecasts Some of the companies mentioned include: - Abbott Diagnostics - Beckman Coulter, Inc. - Clarient, Inc. - DiagnoCure, Inc. - Enigma Diagnostics Ltd. - Fujirebio Diagnostics, Inc. - Gene Logic, Inc. - Hologic, Inc. (formerly Cytyc Corporation) - Immunicon Corporation (now Veridex, LLC) - LabCorp - Matritech - Nuvelo, Inc. - Oncotech, Inc. - Polymedco, Inc. - Qiagen - Roche (F. Hoffman-La Roche, Ltd.) - Siemens Heathcare Diagnostics - Tosoh Corporation (Bioscience division) - Veridex, LLC - Vermillion, Inc. - Worldwide Medical Corporation - Xenomics, Inc. (TrovaGene, Inc.) For more information visit and a full list of the companies mentioned in this report go to http://www.researchandmarkets.com/research/pp...diagnostic About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 48

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 117

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
Gaotu Techedu's Q3 Results: A Look at AI-Driven Growth

Updated Category News Views 56

Gaotu Techedu to Unveil Q3 Results Mark your calendars, folks—Gaotu Techedu Inc. (NYSE: GOTU) is gearing up to dish out its third quarter financial results on November 25, 2026. As usual, these numbers will slide out before the U.S. markets spring into action. It's one of those moments when investors like us strap in and watch for any movement that might toss our...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 79

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 382

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 59

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 421

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 87

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Voices: Chicago's Latina Trailblazers Unite

Updated Category News Views 156

Empowering Voices: Chicago's Latina Trailblazers Unite The Chicago History Museum is set to host a remarkable celebration of the book, Chicago Latina Trailblazers. This event recognizes the contributions of remarkable Latina leaders through compelling narratives of activism and community service. Event Overview On a significant date that marks a celebration of Latina...

Continue Reading
Mark Green to Keynote CyberScape Summit Focused on Cybersecurity

Updated Category News Views 132

Mark Green to Keynote CyberScape Summit U.S. House Homeland Security Committee Chairman Mark Green is set to showcase his insights as the keynote speaker for GovCIO Media & Research's CyberScape Summit. The event promises to be an essential gathering for those interested in advancing cybersecurity practices and policies within the government. Focus on Cybersecurity and...

Continue Reading
Brian D. Pieninck Takes Leadership Role at GuideWell

Updated Category News Views 539

Brian D. Pieninck Assumes Role as GuideWell President & CEO GuideWell Mutual Holding Corporation has recently made a significant executive decision by appointing Brian D. Pieninck as the new president and chief executive officer (CEO), effective October 1. Previously, Pieninck served as the president and CEO of CareFirst BlueCross BlueShield and was the Board Chair for...

Continue Reading
Calidi Biotherapeutics Unveils Promising CLD-401 Data at SITC

Updated Category News Views 175

Calidi Biotherapeutics Showcases CLD-401 at SITC Calidi Biotherapeutics, Inc. (NYSE: CLDI), a clinical-stage biotechnology firm, recently presented impactful new data regarding its lead therapeutic candidate CLD-401 during the Society for Immunotherapy of Cancer (SITC) Annual Meeting. This presentation highlighted the innovative capabilities of Calidi’s RedTail...

Continue Reading
Everlight Solar: Milwaukee's Top Pick for Eco Energy

Updated Category News Views 21

A High Wattage Win for Everlight Solar Milwaukee seems to have found its favorite solar squad, and it’s none other than Everlight Solar, folks. They’ve locked in the 2026 Milwaukee's Top Choice in the Solar Services Company category. Now, that’s a badge you wear with pride when it's handed out by the very community you serve. It's not every day you see a company...

Continue Reading